The Effect of Lying Position on Hemodynamic Parameters in Patients With Mechanical Ventilated and Spontaneously Breathing.

July 31, 2024 updated by: Sevil Olğun, Aydin Adnan Menderes University

The Effect of Lying Positions on Hemodynamic Parameters in Intensive Care Patients

Aim: The study was carried out to examine the effect of lying positions on hemodynamic parameters in patients with mechanical ventilation (MV) and spontaneous breathing.

Material and Methods: The research was carried out semi-experimentally with a single-group posttest design, between November 2021 and May 2022 in the Internal Medicine Intensive Care (ICU) Unit a University Hospital. The study of the sample consisted of 60 patients in the ICU. Data were collected with the patient identification form and the hemodynamic parameters follow-up form. The patients were given different lying positions for 3 days. Hemodynamic parameters were measured and recorded at the 10th minute, 1st hour and 2nd hour after position changes. The measurement results obtained were compared with one-way ANOVA test.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Aim: The study was carried out to examine the effect of lying positions on hemodynamic parameters in patients with mechanical ventilation (MV) and spontaneous breathing.

Material and Methods: The research was carried out semi-experimentally with a single-group posttest design, between the dates of 15.11.2021 and 15.05.2022 in the Internal Medicine Intensive Care (ICU) Unit a University Hospital. Since repeated measurements were planned in the study when determining the sample, A-priori power analysis was performed based on ANOVA repeated measures analysis and the effect size was calculated according to the etasquared value (Abd El-Aziz et al., 2021). Accordingly, the sample of the study was calculated as 34 patients to reach at least 80% power within a 95% confidence interval. The research was completed with a total of 60 patients who were spontaneously breathing (n=30) and mechanically ventilated (n=30). Data were collected with the patient identification form and the hemodynamic parameters follow-up form. Right lateral, semi Fowler's, left lateral and supine positions were applied to the patients every 2 hours between 9 am 5 pm for 3 days and then pulse rate, respiratory rate, systolic blood pressure (SBP), diastolic blood pressure (DBP) and oxygen saturation (SpO₂) were measured at 10th minute, 1st hour and 2nd hour. In data analysis, number, arithmetic mean, standard deviation, chi-square, independent groups t test and one-way ANOVA test were used.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aydın, Turkey, 09010
        • Sevil Olğun

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Hospitalized in intensive care for at least 3 days
  • over 18 years of age
  • monitored
  • spontaneously breathing or connected to a mechanical ventilator,
  • conscious or unconscious,
  • receiving or not receiving oxygen support,
  • with or without a tracheostomy,
  • hemoglobin level of 8g/dl.

Exclusion Criteria:

  • Patients with movement restrictions
  • inotropic/vasopressor and sedative group medications
  • body temperature of 38˚C and above
  • patients receiving CPAP (Continuous Positive Airway Pressure) treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: lying positions
All patients were placed in supine, semi-fowler's and lateral positions, respectively. The effects of positions on hemodynamic parameters were examined.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory rate
Time Frame: Measurements were made 3 times a day (10th minute, 1st hour and 2nd hour) for 3 days.
The patients' respiratory rate were measured and compared separately in the supine semi-fowler's and lateral positions.
Measurements were made 3 times a day (10th minute, 1st hour and 2nd hour) for 3 days.
oxygen saturation
Time Frame: Measurements were made 3 times a day (10th minute, 1st hour and 2nd hour) for 3 days.
The patients' oxygen saturation were measured and compared separately in the supine semi-fowler's and lateral positions.
Measurements were made 3 times a day (10th minute, 1st hour and 2nd hour) for 3 days.
Arterial blood pressure
Time Frame: Measurements were made 3 times a day (10th minute, 1st hour and 2nd hour) for 3 days.
The patients' arterial blood pressure were measured and compared separately in the supine semi-fowler's and lateral positions.
Measurements were made 3 times a day (10th minute, 1st hour and 2nd hour) for 3 days.
pulse rate
Time Frame: Measurements were made 3 times a day (10th minute, 1st hour and 2nd hour) for 3 days.
The patients' pulse rate were measured and compared separately in the supine semi-fowler's and lateral positions.
Measurements were made 3 times a day (10th minute, 1st hour and 2nd hour) for 3 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2021

Primary Completion (Actual)

November 15, 2021

Study Completion (Actual)

May 15, 2022

Study Registration Dates

First Submitted

July 1, 2024

First Submitted That Met QC Criteria

July 31, 2024

First Posted (Estimated)

August 5, 2024

Study Record Updates

Last Update Posted (Estimated)

August 5, 2024

Last Update Submitted That Met QC Criteria

July 31, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe